Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Expert Opinion on Investigational Drugs|July 3, 2026
Advancements in longevity pharmacology research - are we finally seeing clinical progression?Madia Lozupone
Neural Regeneration Research|July 25, 2023
Impact of apolipoprotein E isoforms on sporadic Alzheimer's disease: beyond the role of amyloid betaMadia Lozupone, Francesco Panza
Handbook of Clinical Neurology|August 24, 2023
Passive tau-based immunotherapy for tauopathiesFrancesco Panza, Vincenzo Solfrizzi, Antonio Daniele, et al.
Expert Opinion on Pharmacotherapy|July 16, 2026
Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer's disease?Francesco Panza, Vittorio Dibello, Antonio Daniele, et al.
Ageing Research Reviews|August 28, 2019
Do anti-amyloid-β drugs affect neuropsychiatric status in Alzheimer's disease patients?Francesco Panza, Madia Lozupone, Antonello Bellomo, et al.
Expert Opinion on Investigational Drugs|July 14, 2020
Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectivesBruno P Imbimbo, Madia Lozupone, Mark Watling, et al.
Nature Reviews. Neurology|January 6, 2019
A critical appraisal of amyloid-β-targeting therapies for Alzheimer diseaseFrancesco Panza, Madia Lozupone, Giancarlo Logroscino, et al.
Annals of Neurology|January 13, 2019
Amyloid-β immunotherapy for alzheimer disease: Is it now a long shot?Francesco Panza, Madia Lozupone, Davide Seripa, et al.
Expert Opinion on Pharmacotherapy|October 6, 2020
Pharmacological management of dementia with Lewy bodies with a focus on zonisamide for treating parkinsonismFrancesco Panza, Madia Lozupone, Mark Watling, et al.
Epigenomics|November 17, 2021
Could epigenetics play a role in suicidal behavior in older age?Madia Lozupone, Anita Mollica, Giuseppe Berardino, et al.
Pageof 15